No Data
Express News | Inovio Pharmaceuticals Inc - No Serious Adverse Events Identified in Retrospective Trial
Express News | Inovio Pharmaceuticals Inc - New Data to Inform Re-Dosing Strategy for Rrp Treatment
Express News | New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
INOVIO Reports Inducement Grant Under Inducement Plan
World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.